Latest News
From November 26 to 29, the 7th edition of the Mapping Course Bellvitge is taking place at Bellvitge Hospital and the Bellvitge University Campus, where the latest advances in neurosurgery with intraoperative mapping, neurophysiological monitoring, and surgical neuropsychological assessment are being presented.
An international multicenter study, involving the Bellvitge University Hospital and IDIBELL, has shown that the drug semaglutide, designed to treat diabetes and obesity, protects the kidney in obese non-diabetic patients with chronic kidney disease.
The procedure was carried out by the renowned surgeon Diego González Rivas, in collaboration with thoracic surgeons from Bellvitge Hospital and a large multidisciplinary team.
The minimally invasive robotic approach marks a milestone in the treatment of high-complexity tumors.